Modular Medical Receives IRB Approval to Deliver Insulin Using Pivot Patch Pump

Core Insights - Modular Medical, Inc. has received Institutional Review Board (IRB) approval to conduct an in-house study of its next-generation Pivot™ insulin delivery system targeting the diabetes market [1] Company Overview - Modular Medical is focused on innovative insulin delivery technology aimed at the $3 billion adult "almost-pumpers" diabetes market [1] - The company offers user-friendly and affordable patch pumps for diabetes management [1] Regulatory Approval - The IRB approval is a significant step in compliance with U.S. Food and Drug Administration (FDA) regulations for conducting biomedical research involving human subjects [1]